Detalhe da pesquisa
1.
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.
J Sleep Res
; : e14164, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351662
2.
[New Therapeutic Approaches for Chronic Insomnia]. / Neue Therapieansätze bei chronischer Insomnie.
Fortschr Neurol Psychiatr
; 91(10): 419-431, 2023 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-37848019
3.
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation.
J Neuroinflammation
; 14(1): 41, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28231856
4.
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
J Neuroinflammation
; 14(1): 172, 2017 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859672
5.
Letter to the editor regarding "Therapeutic drug monitoring of natalizumab".
Mult Scler
; 26(6): 741-742, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943104
6.
Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".
Mult Scler
; 24(6): 820-822, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805095
7.
A pragmatic methodical framework for the user-centred development of an electronic process support for the sleep laboratory patients' management.
Digit Health
; 8: 20552076221134437, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325436
8.
Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration.
Front Neurol
; 11: 391, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477253
9.
Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study.
J Mol Med (Berl)
; 97(9): 1263-1271, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243520